A previously healthy 25-year-old mother of two preschool children, aged 2 and 4 years, was seen by her primary provider for ...
GlobalData on MSN
ImmunityBio’s allogeneic CD19 cell therapy shows complete response beyond 15 months
ImmunityBio’s stock rose nearly 40% after it announced the Phase I data and Anktiva sales figures for 2025.
Objectives Understanding the molecular changes in the preclinical synovium is crucial for identifying factors that drive ...
Unlike common viral fevers, dengue can cause more severe illness. “Dengue virus directly suppresses bone marrow, reducing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results